Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

National Institute of Allergy and Infectious Disease
NIH 3D
FAQsBioArt

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

NIH3D

APOLIPOPROTEIN E4 (APOE4), 22K FRAGMENT

PDB 1B68
was used by NIH 3D workflows to automatically generate models for
nevitdilmen
Created:
5/30/16
Submitted:
10/6/26
Published:
10/6/26
thin ribbon, secondary structure
1b68-ribbon-thin-secondaryThin ribbon representation colored by secondary structure (a-helix: blue, B-sheet: red, coil: yellow).

Select an image below to view

thin ribbon, secondary structurethin ribbon, rainbowthin ribbon, by chainthin ribbon, no colorthick ribbon, secondary structure, print cautionthick ribbon, rainbow, print cautionthick ribbon, by chain, print cautionthick ribbon, no color, NIH 3D repaired

lo-res mol surface, by chainlo-res mol surface, hydrophobicitylo-res mol surface, coulombiclo-res mol surface, no colorhi-res mol surface, by chain, print cautionhi-res mol surface, hydrophobicity, print cautionhi-res mol surface, coulombic, print cautionhi-res mol surface, no color, print caution

Learn more about NIH 3D workflow outputs

3DPX-003358

NIH 3D DOI:

https://doi.org/10.60705/3dpx/3358.3

Licensing:

Public Domain
How to cite this NIH 3D entry
377
26
Version 3

Category

Biomacromolecules
Biomacromolecules
Description
PDB Classification: LIPID TRANSPORT
Source Data Details
Attribution Instructions
Combinatorial Engineering of Proteolytically Resistant APPI Variants that Selectively Inhibit Human Kallikrein 6 for Cancer Therapy

3DPX-014489

by benhur974

Combinatorial Engineering of Proteolytically Resistant APPI Variants that Selectively Inhibit Human Kallikrein 6 for Cancer Therapy